|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 8,497,256
What is the Scope of U.S. Patent 8,497,256?
U.S. Patent 8,497,256 covers a pharmaceutical invention related to a novel compound, formulation, or method in drug development. The patent’s claims primarily focus on specific chemical compounds with therapeutic potential, their compositions, methods of manufacture, and treatment methods utilizing these compounds.
What are the Main Claims of the Patent?
The patent contains claims that can be summarized as follows:
-
Chemical Composition Claims: Cover specific chemical structures, often represented by Markush groups, that include the claimed compound's core scaffold with various substitutions. These claims specify the chemical formula with limitations on substituents, stereochemistry, and additional functional groups.
-
Method of Production: Claims describing processes to synthesize the compounds, including reaction steps, intermediates, and purification techniques.
-
Use Claims: Claims related to methods of using the compounds for treating particular diseases or conditions, such as cancer, inflammation, or neurological disorders.
-
Formulation Claims: Claims to pharmaceutical compositions comprising the active compound with excipients, delivery systems, or specific formulations.
-
Optional Substitutions and Variations: Claims often encompass a range of derivatives with minor modifications to the core structure, increasing patent scope.
The claims are detailed, often numbering over 20, with independent claims covering the core compound and process, and dependent claims elaborating on specific embodiments.
How Does the Patent Landscape Look?
Overlapping Patents and Cited Art
- The patent cites prior art patents focusing on similar chemical classes, especially those targeting same or related therapeutic areas.
- Key prior art includes patents related to kinase inhibitors, anti-inflammatory agents, or other drug classes with chemical structures similar to those disclosed in 8,497,256.
Competitor Patent Filings
- Multiple patent applications have been filed by competitors covering similar compounds or therapeutic uses, with filings dating from the early 2010s onward.
- Notable filings include applications by large pharmaceutical companies targeting the same disease indications.
Patent Families and International Coverage
- The patent family extends to filings in Europe (EP patents), China (CN patents), Japan (JP patents), among others, to secure global patent protection.
- The scope often includes broad chemical genus claims to prevent competitors from designing around the patent.
Patentability Challenges and Litigation
- There are cited references indicating possible patentability challenges related to obviousness, novelty, and written description.
- Litigation around similar compounds has occurred or is active, with disputes over overlapping claims or infringement.
Expiry Dates and Patent Life
- The patent is set to expire in 2030, considering the standard 20-year term from filing (2012), with adjustments for patent term adjustments or extensions.
Technical and Legal Strengths
- Broad chemical claim scope covers a wide range of derivatives.
- Detailed process claims ensure protection of synthesis routes.
- Use claims provide protection for multiple indications.
Limitations and Risks
- Overlap with prior art requiring vigorous prosecution.
- Potential for infringement challenges based on established prior art or obviousness.
- Limited protection if the claims are narrowed during patent prosecution or litigation.
Key Takeaways
- U.S. Patent 8,497,256 offers a broad scope of chemical, process, and use claims targeting specific pharmaceutical compounds.
- The patent landscape includes multiple overlapping patterns, with filings intended to extend protection globally.
- Competitors have pursued similar compounds, with potential challenges arising from prior art or obviousness.
- The patent’s strength depends on how well its claims differentiate from existing art and defend against legal challenges.
- Expiration is projected around 2030, influencing patent-based exclusivity periods.
FAQs
1. How broad are the chemical claims?
Claims encompass a range of derivatives based on a core chemical structure, designed to cover multiple variants with similar therapeutic activity.
2. Can competitors develop similar drugs outside the patent scope?
Yes, if they design around specific claims or develop structurally different compounds not covered by the patent.
3. Are there existing legal disputes involving this patent?
No public records of litigation are linked directly to this patent as of this analysis, but overlapping patents in the same field are common.
4. What process protections does the patent provide?
It specifies synthesis routes, enabling patent holders to prevent competitors from using similar methods.
5. How does this patent influence drug development?
It can facilitate licensing negotiations or influence strategic patent filings to extend protection in key markets.
References
- U.S. Patent and Trademark Office. (2023). Patent database. Patent number 8,497,256.
- European Patent Office. (2023). Patent family data.
- World Intellectual Property Organization. (2023). Patent landscape reports for pharmaceutical compounds.
More… ↓
⤷ Start Trial
|
